Transitional Cell Carcinoma Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Transitional Cell Carcinoma?
Urothelial carcinoma (transitional carcinoma) begins in the urothelium, the tissue lining some areas of the urinary system. About 90% of bladder cancer cases and 7% of kidney cancer cases, including cancer of the renal pelvis and ureter, are caused by urothelial carcinoma. The symptoms of urothelial carcinoma-induced bladder and kidney cancers are comparable. Their prognoses are similar; these malignancies are easily treated when detected early but frequently return.
How does urothelial carcinoma affect my body?
Urothelial carcinoma affects the bladder and kidneys in various ways. Bladder abnormal urothelial cells can move from the lining to deeper structures, potentially travelling to distant sites such as the liver, lungs, bones, fatty tissues, and lymph nodes. Low-grade bladder cancer is not likely to metastasise, whereas high-grade disease can be lethal and might recur. Urothelial carcinoma in the kidney may progress to develop tumours in the renal pelvis or ureter, which may then extend to other organs. Both diseases, if not treated, may lead to severe implications.
What is the Importance of Timely Treatment?
Transitional cell carcinoma (TCC), also known as urothelial carcinoma, needs to be treated early to enhance prognoses and prevent the cancer from spreading. If diagnosed early, TCC is often successfully treated with less invasive methods, such as localised or transurethral resection. Postponing therapy may make treatment more difficult and reduce survival by giving the cancer time to move to other parts of the body, such as the liver, lungs, or lymph nodes, or grow deeper into the bladder. Early treatment significantly enhances the outlook for individuals with TCC, controls symptoms, and prevents recurrence.
What are the Common Symptoms of Transitional Cell Carcinoma?
Symptoms of urothelial cancer may not be present at once. Usually, the first noticeable sign is blood in the urine. You should consult a healthcare provider if you notice any symptoms, including blood in the urine.
- Chronic pain in the back.
- Fatigue.
- Unexplained weight loss.
- Dysuria is painful urination.
- Tumour or lump near your kidneys.
- Low-grade fever.
Causes and Risk Factors of Transitional Cell Carcinoma
Causes
The exact aetiology of urothelial carcinoma in the kidneys and bladder is not known to medical scientists. They have found, however, a few common risk factors:
- Cigarette smoke: Smoking cigarettes increases the risk of urothelial carcinoma-related urinary system malignancies.
- Exposuretocertainchemicals: Studies show that individuals who work with chemicals used in paint, leather, rubber, dyes, certain fabrics, and hair care products are at increased risk for urinary system malignancies linked to urothelial carcinoma.
Risk Factors
Some risks of transitional cell carcinoma are mentioned below:
- Smoking
- Exposure to chemicals
- Family history
- Genetic factors
Connect with our advisor for a PRIORITY response
Transitional Cell Carcinoma Prevention Tips
Although there is no guaranteed method to prevent Transitional Cell Carcinoma (TCC), the most important things you can do to lower your risk are to stop smoking, limit your exposure to certain chemicals at work, drink lots of water, and eat a diet high in fruits and vegetables.
Treatment options for Transitional Cell Carcinoma
Surgery is the primary treatment for localised TCC. This includes partial nephrectomy for kidney tumours and transurethral resection for bladder tumours. In certain situations, a radical cystectomy (removal of the bladder) or nephrectomy (removal of the kidney) may be necessary.
Chemotherapy: isfrequently used to eradicate any cancer cells that remain after surgery or for advanced TCC. Chemotherapy is administered intravenously or directly into the bladder for superficial bladder tumours.
Cost Start From USD 600 - USD 700Explore Options
Immunotherapy: Pembrolizumab and other immune checkpoint inhibitors are used more frequently, particularly for advanced or metastatic TCC, since they aid the immune system in recognising and combating cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Radiation therapy is used to decrease tumours before surgery, particularly for bladder TCC, or to treat tumours in locations that are challenging for surgery to reach.
Targeted Therapy: Medications that attack cancer cells specifically based on genetic mutations or tumor-specific proteins are applied in targeted therapy for urothelial carcinoma. The medications can block the signals through which cancer cells grow and disseminate.
Cost Start From USD 8000 - USD 12000Explore Options
Urinalysis: A test to determine the colour of your urine and its components, including germs, blood, protein, and sugar.
Urine cytology: Medical professionals use a microscope to look for abnormal cells in your urine. Cancer cells may leak into your urine if you have cancer in your kidneys, bladder, or ureter.
An intravenous pyelogram (IVP) is a sequence of X-rays of the kidneys, ureter, and bladder to screen for malignancy. Medical professionals inject a contrast dye into one of the veins. To check for obstructions, physicians take X-rays as the dye passes through the kidneys, ureter, and bladder.
Ureteroscopy: To view the ureter and renal pelvis and acquire tissue samples, healthcare professionals use a narrow, tube-like device with a light and viewing lens.
Computed tomography (CT) scans provide detailed images of your internal organs by connecting a computer to an X-ray machine. Computerised tomography or computerised axial tomography are other names for this process.
Ultrasound: A process that creates echoes by reflecting high-energy sound waves off of inside organs or tissues. A sonogram is an image of bodily tissues produced by the echoes. Medical professionals may perform an abdominal ultrasound to help in the diagnosis of renal pelvic and ureter cancer.
Magnetic resonance imaging (MRI) involves creating finely detailed images of body parts, such as the pelvis, using a magnet, radio waves, and a computer. Nuclear magnetic resonance imaging (NMRI) is another name for this process.
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support Transitional cell Carcinoma patients in India. These services include:
- Physical therapy enhances strength, endurance, and mobility after chemotherapy or surgery.
- Occupational therapy: Helping the patient return to usual work and activities, especially after invasive treatment such as surgery or chemotherapy.
- Depending on the situation, your healthcare professional may prescribe medicine to help control your symptoms and support the treatment plan.
Instantly Connect with our Specialists
Hospitals for Transitional Cell Carcinoma in India
American Oncology Institute
Hyderabad, India
American Oncology Institute located in Hyderabad, India is accredited by AAAHC. Also listed below are some of the most prominent infrastructural details:
- Equipped with the most advanced technology
- TruebeamStx + Calypso combination used for precise radiation therapy
- Backed by advanced equipment like 4D PET CT Imaging, Luminous Acupulse DUO laser, Rapid Arc, MRI, Brachytherapy, Digital Mammography
- Radiation oncology techniques- Intensity Modulated Radiation Therapy, Rapid Arc, Image-Guided Radiation Therapy,
- Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy
- All types of patient accommodation available which provide a comfortable stay to the patients & relatives.
- Fully equipped ICUs with the latest monitoring & therapeutic facilities for critically ill patients
- In house 24/7 blood bank for medical oncology service
- Well-designed patient rooms, therapy rooms OTs, consultation chambers, ICUs, walkways, lounges, parking
- Digital Breast Tomosynthesis is the breast imaging digital technology with 3D imaging
- Dedicated leukemia wing caters to the needs of the patients who are at a high risk of developing an infection
- State-of-the art PET CT, GE Discovery IQ 3 Ring16 PET with LightBurst technology
- Individual cabins for patients needing chemotherapy
- Friendly facility for differently-abled
- Exclusive outpatient consulting section
- Airport pick-up & drop
- Accommodation
- Currency exchange
- The estimated cost of treatment
- Language interpreters
- Payment
- Medical opinion
- Additional services
- Relationship manager
- Meals
- 24/7 Personal nurses*
- Visa assistance
The Madras Institute of Orthopedics and Traumatology
Chennai, India
MIOT started its journey with only 70 beds and focusing on Orthopedics and Trauma care. However, we grew into a multi-specialty hospital with time. MIOT is now a 1000-bedded hospital and can offer an extensive range of services across 63 specialties. The state of art laboratory of our hospital is ranked 8th internationally. We have 21 super-specialty operation theaters equipped with cutting-edge technology to help our doctors with complex procedures.
We take great care to make our patient rooms comfortable enough. The patient rooms get plenty of fresh air as well as natural light. The soothing views from the rooms do not let the patients feel cut off from the outside world. We use separate entrances for emergency patients, out-patients, in-patients, and their attendants. We put our patients’ safety first which is why we use a superior air system to ensure a near-zero infection healthy environment.
Apart from that, MIOT’s 24 hours blood bank provides all kinds of blood work related services which include blood collection to component separation. This state-of-art blood bank alone handles more than 30,000 units of blood over the course of a year. Every month around 600 blood transfusions are managed by this blood bank.
MIOT’s SIGNA Pioneer 3T MRI machine is made with noise reduction technology. This silent MRI machine can deliver superior quality neuroimages without wasting any time. The department of Radiology and Imaging Sciences can give tough competition to any international hospital with its advanced technology and accuracy.
The PET CT service at MIOT International is the first of its kind in South India enabling better and more accurate diagnosis than earlier. The superior diagnosis is also possible for the two digital cath labs at MIOT Heart Revive center.
We also have a physiotherapy team where a team of highly efficient physiotherapists deals with the mobility and functional disability issues of our patients. They listen to the patients carefully to identify the root of the pain and use therapeutic exercises to reduce their pain.
The CCU of MIOT is something to be proud of. The specially-trained staff of this unit is dedicated to ensuring top-quality medical support to serious patients. This unit along with the MIOT International Laboratory is the backbone of our facility.
Furthermore, what makes MIOT unique is our Telemedicine service. In the new normal, we are trying everything to reach our patients. Our one of its kind Telemedicine service connects our patients to our 250 full-time doctors over email, phone, chat and video consultations.
Sanar International Hospital
Gurugram, India
Sanar International Hospital is a multispeciality hospital based on Golf Course Road in Gurugram, a part of Delhi NCR. It was founded in 2018 and houses one of the most comprehensive and advanced surgical care specialties. This 150-bedded facility is committed to providing the best patient experiences and healthcare services is the core of the hospital’s mission. Staffed by a group of visionary and competent medical professionals who are well-versed in their fields and eminent for their empathy and understanding, Sanar International Hospital provides optimal care to its patients, making it a popular
Specialties in the Hospital such as Heart, Bone, and Joint neurosciences, Cancer, Kidney and Liver Transplant, and other successful procedures along with experienced medical professionals have made a mark for themselves among domestic patients and international patients who come to India to have the finest healthcare services. It follows strict international practices and believes that the centricity of the patient is essential for providing high-quality care through world-class infrastructure and state-of-the-art facilities. The technologies offered by the Hospital include Digital X-rays, MRI, CT, Ultrasound, transfusion medicine, pharmacy, laboratory services, 24 hrs emergency and ambulance services.
It offers more than 20 plus specialties such as General Medicine, Anesthesiology, Cardiac Sciences, Ophthalmology, Gastroenterology, Hematology, Orthopedics, General Surgery & Surgical, Cardiothoracic Surgery, Hepato Biliary Surgery, Pediatrics, Liver Transplantation, and Critical Care Medicine. The Hospital has a highly skilled medical staff of neuro-anesthetists, neurologists, specialized neurocritical care experts, neurosurgeons neuropsychologists, and neuropsychiatrists. There are specific centers for the treatment of epilepsy, stroke, brain tumors, movement disorders, spinal problems, and headaches.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Transitional Cell Carcinoma Treatment?
India is an excellent place for transitional cell carcinoma treatment because of its top-notch medical facilities, qualified oncologists, and best-in-class treatment facilities at reasonable prices. The nation has the latest technology-equipped state-of-the-art hospitals to facilitate effective diagnosis and treatment. Indian hospitals are also internationally accredited, offering high-quality care.
Frequently Asked Questions
Early-stage TCC kidney carcinoma may have over 90% survival, as the National Carcinoma Institute (NCI) reported. The survival rate may be 15% or below if the TCC has progressed past the bladder's inner lining or to other body parts.
The diagnosis of Transitional Cell Carcinoma, or TCC, is more prevalent among older individuals, particularly in India, who are over the age of 55. It is more prevalent among men compared to women. With age, the risk increases due to factors such as prolonged exposure to carcinogens (such as nicotine and industrial chemicals) and the additive effects of long-standing renal or bladder diseases.
Since smoking is one of the substantial risk factors for bladder, kidney, and ureter cancers, it plays a significant role in developing Transitional Cell Carcinoma (TCC) in India. Aromatic amines and various carcinogens present in tobacco smoke are absorbed into the bloodstream, filtered through the kidneys, and finally excreted in urine. These compounds can damage healthy urinary tract cells, causing mutations and the development of TCC. In India, smoking is believed to increase an individual's risk of developing TCC by as much as three times for both genders. It is one of the country's leading preventable causes of TCC.
In India, transitional cell carcinoma (TCC), especially of the bladder and ureters, can recur after treatment. TCC is a high-recurrence tumour, especially in superficial or early-stage cases, even after successful initial treatment, e.g., surgery or chemotherapy.
Regular follow-up with imaging, urine examination, and cystoscopy is mandatory to detect any recurrence at an early stage. Recurrence may be more aggressive and more challenging to manage in advanced cases. To manage the risk of recurrence, Indian patients are advised to undergo therapy and monitoring on a routine basis.
In India, radiation therapy is used to cure Transitional Cell Carcinoma (TCC) in cases where the tumour is incurable or advanced. It is also commonly used to cure bladder cancer, either alone or as a means to destroy cancer cells that remain even after surgery.
Radiation therapy can be combined with chemotherapy for better results. However, due to anatomical challenges, its use is limited to TCC, which aims to decrease symptoms, reduce tumours, and improve the overall quality of life.
Lifestyle and dietary changes can improve overall health and treatment outcomes for TCC patients in India. Some recommendations include
- Drinking plenty of water to help remove toxins and reduce the risk of recurrence.
- Consuming a diet rich in whole grains, fruits, and vegetables to enhance overall health and immunity.
- Reducing the risk of cancer by eating less processed food and red meat.
- Decreasing alcohol intake and smoking can enhance the recovery process and reduce the risk of cancer development.
- Maintaining an active lifestyle to cope with stress, build strength, and reduce fatigue.
- Enhancing mental well-being during treatment through taking part in stress-relieving activities such as yoga or meditation.